Gregg Davis

Gregg Davis is an accomplished executive with extensive experience in business development and corporate strategy within the biopharmaceutical industry. Currently serving as Vice President of Business Development at Arcutis Biotherapeutics, Inc., Davis has held similar leadership roles at Affinia Therapeutics, BeyondSpring, Seed Therapeutics, and Asklepios BioPharmaceutical, Inc. Notable achievements include closing multiple transactions, developing innovative due diligence processes, and leading corporate development efforts to align company pipelines with strategic goals. Prior to these roles, Davis co-founded FLAG Therapeutics and served as Chief Business Officer, as well as held key positions at Patheon Inc., GlaxoSmithKline, and Eno River Capital. Davis holds both a BA and an MBA from the University of North Carolina at Chapel Hill.